Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma
- PMID: 9699534
- DOI: 10.1002/(sici)1097-0215(19980821)79:4<402::aid-ijc16>3.0.co;2-6
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma
Abstract
The membrane-bound MUC1 mucin is expressed in normal mucosas and the aberrant expression of its under-glycosylated forms has been reported in carcinomas from different sites. Several studies have provided conflicting evidence regarding the relationship between MUC1 expression and outcome in cancer patients. In this study, we investigated the immunohistochemical expression of MUC1 epitopes, using 2 monoclonal antibodies (MAbs): HMFG1, which reacts with the fully glycosylated MUC1, was studied in 73 gastric carcinomas; and SM3, which recognises an under-glycosylated form of MUC1, was studied in 180 cases. HMFG1 stained the antrum foveolar cells and the body glands of normal gastric mucosa, whereas SM3 reactivity was restricted to the perinuclear region of some foveolar cells. Type I intestinal metaplasia exhibited down-regulation of MUC1 expression using both MAbs. Every gastric carcinoma was stained with HMFG1 and 80% with SM3. High levels of expression of HMFG1 were associated with lymphatic invasion, nodal metastatization, and advanced pTNM staging. The expression of SM3 was associated with the histologic (solid) type of carcinoma, expanding growth pattern, wall penetration, lymphatic invasion and age of the patients. Despite a trend for a poor outcome in patients with tumours (over)expressing MUC1 mucin, the survival of the patients evaluated by univariate and multivariate analysis was not significantly associated with the levels of expression of HMFG1 or with the expression of the SM3 epitope. We conclude that (a) MUC1 expression, namely of the SM3 cancer-associated epitope, is significantly associated with several aspects of gastric cancer development and progression; and (b) MUC1 expression should not be used as a prognostic marker in patients with gastric carcinoma.
Similar articles
-
Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.Int J Cancer. 1998 Apr 17;79(2):133-8. doi: 10.1002/(sici)1097-0215(19980417)79:2<133::aid-ijc6>3.0.co;2-u. Int J Cancer. 1998. PMID: 9583726
-
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.Clin Cancer Res. 1998 Nov;4(11):2605-14. Clin Cancer Res. 1998. PMID: 9829723
-
Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.Int J Oncol. 2005 Nov;27(5):1289-97. Int J Oncol. 2005. PMID: 16211224
-
MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis.Dis Markers. 2016;2016:9421571. doi: 10.1155/2016/9421571. Epub 2016 Apr 17. Dis Markers. 2016. PMID: 27190429 Free PMC article. Review.
-
MUC1: An emerging target in cancer treatment and diagnosis.Bull Cancer. 2022 Nov;109(11):1202-1216. doi: 10.1016/j.bulcan.2022.08.001. Epub 2022 Sep 30. Bull Cancer. 2022. PMID: 36184332 Review.
Cited by
-
High-sensitivity analytical approaches for the structural characterization of glycoproteins.Chem Rev. 2013 Apr 10;113(4):2668-732. doi: 10.1021/cr3003714. Epub 2013 Mar 27. Chem Rev. 2013. PMID: 23531120 Free PMC article. Review. No abstract available.
-
An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia.Gut Liver. 2013 Nov;7(6):688-95. doi: 10.5009/gnl.2013.7.6.688. Epub 2013 Nov 11. Gut Liver. 2013. PMID: 24312710 Free PMC article.
-
Apical MUC1 expression revealed on the foveolar epithelium in H. pylori gastritis.Br J Cancer. 2013 Mar 19;108(5):1113-8. doi: 10.1038/bjc.2013.54. Epub 2013 Feb 14. Br J Cancer. 2013. PMID: 23412104 Free PMC article.
-
Antibody profiling with protein antigen microarrays in early stage cancer.Expert Opin Med Diagn. 2012 May;6(3):187-96. doi: 10.1517/17530059.2012.672969. Epub 2012 Mar 22. Expert Opin Med Diagn. 2012. PMID: 23480685 Free PMC article.
-
Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.PLoS One. 2015 Jul 29;10(7):e0134458. doi: 10.1371/journal.pone.0134458. eCollection 2015. PLoS One. 2015. PMID: 26222311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous